CARE-MAN - Healthcare by Biosensor Measurements And Networking (FP6-NMP) (2005-11-01 - 2010-10-31) (»add to infobox)

Guenter GAUGLITZ, Michael STEINWAND, Claudia PREININGER, Ingo TREMPECK, Christoph PETRY, Ingmar DORN, Sonia RODRIGUEZ, Marius BALGER, Francesco BALDINI, Giampiero PORRO, Brian MACCRAITH, François ROSSI, Miroslav SUCHANEK, Albrecht BRANDENBURG, Petra KRAEMER, Josep ROCA, Nathalie JOLLY, Lukas SCHAUPP, Martin ELLMERER, Jiri SKALICKY, Bo LIEDBERG, Adrian KEWELL, Joachim KAISER, Loic BLUM, Marco MASCINI, Nicolas F. DE ROOIJ, Lars BALTZER, Milan FRANEK

EBERHARD-KARLS UNIVERSITAET TUEBINGEN (DE142 - Tübingen, Landkreis) (Germany), APPLERA EUROPE B.V. (NoRegion - NoRegion) (Netherlands), ARC SEIBERSDORF RESEARCH GMBH (AT130 - Wien) (Austria), ATTEMPTO SERVICE GMBH (DE142 - Tübingen, Landkreis) (Germany), BAYER AG (DEA1A - Wuppertal, Kreisfreie Stadt) (Germany), BAYER TECHNOLOGY SERVICES GMBH (DEA24 - Leverkusen, Kreisfreie Stadt) (Germany), BIOTOOLS, BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. (ES300 - Madrid) (Spain), BIT ANALYTICAL INSTRUMENTS GMBH (DE712 - Frankfurt am Main, Kreisfreie Stadt) (Germany), CONSIGLIO NAZIONALE DELLE RICERCHE (IT603 - Roma) (Italy), DATAMED SRL (IT205 - Milano) (Italy), DUBLIN CITY UNIVERSITY (IE002 - Dublin) (Ireland), EUROPEAN COMMISSION JOINT RESEARCH CENTRE (BE100 - Arr. de Bruxelles-Capitale) (Belgium), EXBIO PRAHA (CZ010 - Hlavni mesto Praha) (Czech Republic), FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG EV (DE212 - München, Kreisfreie Stadt) (Germany), GSF - FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT GMBH (DE21H - München, Landkreis) (Germany), HOSPITAL CLINIC I PROVINCIAL DE BARCELONA (ES511 - Barcelona) (Spain), INETSYS (FR105 - Hauts-de-Seine) (France), JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH (AT221 - Graz) (Austria), KARL-FRANZENS-UNIVERSITAET GRAZ (AT221 - Graz) (Austria), KRAJSKA NEMOCNICE PARDUBICE (REGIONAL HOSPITAL PARDUBICE) (CZ053 - Pardubicky kraj) (Czech Republic), LINKOEPINGS UNIVERSITET (SE023 - Östergötlands län) (Sweden), NANOCOMMS LTD (IE007 - South-West (IRL)) (Ireland), SIEMENS AG (DE212 - München, Kreisfreie Stadt) (Germany), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR716 - Rhône) (France), UNIVERSITY OF FLORENCE (IT514 - Firenze) (Italy), UNIVERSITY OF NEUCHATEL (CH024 - Neuchâtel) (Switzerland), UPPSALA UNIVERSITET (SE021 - Uppsala län) (Sweden), VETERINARY RESEARCH INSTITUTE (CZ062 - Jihomoravsky kraj) (Czech Republic)

Diagnostics at hospitals is based either on large-scale automated equipment or ELISA techniques based on bioassays, which are not suitable for bedside and emergency medicine. Therefore CARE-MAN will provide a validated, intelligent, next-generation diagnostic device and system based on biosensor technology with new, radically enhanced detection capabilities and integrated sample-handling to address the most common diagnostic problems in the EU like cardiovascular disease, coagulation disorders, chronic/acute inflammation, cancer, thyroid disorders. The integration of eHealth capabilities is achieved through networking functions and interfaces to current and future medical data systems. To follow the requirements of the variety of serious diseases, modules of sample preparation, fluidics, assay formats and optical and electrochemoluminescent transduction principles will be integrated in a new modular multi-analyte technological system in cooperation with diagnostic and IT companies. The system will reduce sample volumes and improve limit of detection, make the point-of-care diagnostics fast, easy to handle and cost-effective and will provide an anticipating diagnostic help by networking and information technology. Hospitals are involved in the validation process taking into account the differences in healthcare and provide input to improve the instrumentation. Working bio-sensing systems are modified to allow development of immunoassay strategies from the start and give chance to improve instrumental setups even in the first period. Later, system integration will not only set up a technological modular system for hospitals but also for family doctors and in future, for bedside home surveillance. The involvement of legislatory bodies and representatives of health insurances in an advisory board and the complementary expertise of the partners govern the success and the validity of the project.

PERSONS (28/28)

RELATED NAVIGATION AREA(S) (2/2)